Comparison of the kinetics of 99mTc-sestamibi and 99MTc-tetrofosmin in a multidrug-resistant tumour cell line.

被引：0
|
作者：
Utsunomiya, K [1 ]
Ballinger, JR [1 ]
Zhang, X [1 ]
Su, ZF [1 ]
Tsuchida, T [1 ]
Ichise, M [1 ]
机构：
[1] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1999年 / 26卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OS346
引用
收藏
页码：1047 / 1047
页数：1
相关论文
共 50 条
  • [1] Comparison of the kinetics of 99mTc-sestamibi and 99mTc-tetrofosmin in a multidrug-resistant tumour cell line
    Utsunomiya, K
    Ballinger, JR
    Zhang, XG
    Su, ZF
    Tsuchida, T
    Ichise, M
    RADIOLOGY, 1999, 213P : 162 - 162
  • [2] Comparison of 99mTc-sestamibi and 99mTc-tetrofosmin washoutratesfrom parathyroid and thyroid glands
    Athanasoulis, T.
    Valsamaki, P.
    Karantanis, D.
    Daramaras, A.
    Jianakopoulou, P.
    Katsoulis, A.
    Zerva, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S232 - S233
  • [3] Efficiency comparison between 99mTc-tetrofosmin and 99mTc-sestamibi myocardial perfusion studies
    Ravizzini, GC
    Hanson, MW
    Shaw, LK
    Wong, TZ
    Hagge, RJ
    Pagnanelli, RA
    Jain, D
    Lima, HS
    Coleman, RE
    Borges-Neto, S
    NUCLEAR MEDICINE COMMUNICATIONS, 2002, 23 (03) : 203 - 208
  • [4] Monitoring Multidrug Resistance (MDR) in Osteosarcoma Cell Lines with 99mTc-Sestamibi (MIBI) and 99mTc-Tetrofosmin (Tfs)
    Gomes, C. M. F.
    Cleton-Jansen, A. M.
    Welling, M. M.
    van Paassen, H.
    Hogendoorn, P. C. W.
    Abrunhosa, A. J.
    Botelho, M. F.
    Feitsma, R. I. J.
    Pauwels, E. K. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S99 - S99
  • [5] 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
    Fröberg, AC
    Valkema, R
    Bonjer, HJ
    Krenning, EP
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (02) : 193 - 196
  • [6] 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
    Alida C. Fröberg
    Roelf Valkema
    Jaap H. Bonjer
    Eric P. Krenning
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : 193 - 196
  • [7] The breast cancer cell line MCF7 as a model of 99mTc-SestaMIBI, 99mTc-tetrofosmin and 99mTc-medronate incorporation
    Molteni, SN
    Seregni, E
    Botti, C
    Martinetti, A
    Ferrari, L
    Crippa, F
    Bombardieri, E
    ANTICANCER RESEARCH, 1999, 19 (1A) : 255 - 259
  • [8] Performance of 99mTc-tetrofosmin versus 99mTc-sestamibi in murine myocardial perfusion studies
    Vrachimis, Alexis
    Hermann, Sven
    Schober, Otmar
    Schafers, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [9] A comparison of stress 99mTc-Sestamibi and 99mTc-tetrofosmin: visually quality of the images and the need for repeated scans
    Hansen, G.
    Jensen, B. T.
    Kristensen, C.
    Kalia, S.
    Gerke, O.
    Vestergaard, S.
    Johansen, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S499 - S499
  • [10] 99mTc-Tetrofosmin or 99mTc-Sestamibi for double-phase parathyroid scintigraphy.
    Fröberg, AC
    Valkema, R
    Bonjer, HJ
    Krenning, EP
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 326P - 326P
12345